1,720,965 research outputs found
Intravitreal Bevacizumab Treatment for Choroidal Neovascularization in Pathologic Myopia: 12-month Results
No full textPURPOSE: To evaluate the short-term efficacy and safety of intravitreal bevacizumab for the treatment of myopic choroidal neovascularization (CNV). DESIGN: Prospective, nonrandomized, interventional case series. METHODS: Twenty eyes from 20 patients with CNV secondary to pathologic myopia participated in this prospective nonrandomized interventional case series. All patients were scheduled for three monthly intravitreal bevacizumab 1.25 mg injections. Early Treatment Diabetic Retinopathy Study best-corrected visual acuity (BCVA), foveal center thickness (FCT) on optical coherence tomography (OCT), and fluorescein angiographic findings were examined before and after treatment. Patients were followed up for 12 months. RESULTS: The mean BCVA (+/- standard deviation [SD]) at baseline was 24.8 (+/- 11.86) letters (Snellen equivalent: 20/80). At 12 months after treatment, the mean BCVA (+/- SD) improved significantly (P = .000001) to 43 (+/- 12.38) letters (Snellen equivalent: 20/35). At 12 month follow-up, BCVA improved 10 letters or more in 18 (90%) out of 20 treated eyes and improved 15 letters or more in 14 (70%) out of 20 treated eyes. No treated eyes experienced a worsening of BCVA from baseline. The mean FCT (+/- SD) at baseline was 223 (+/- 47.43) microns. At 12 months after treatment, the mean FCT (+/- SD) reduced to 206 (+/- 50.87) microns. This reduction in FCT after treatment was not statistically significant (P = .11). At 12 months follow-up, absence of fluorescein leakage from the CNV was demonstrated in 19 (95%) out of 20 treated eyes and persistent leakage in one eye (5%). None of the 19 eyes that had CNV closure experienced recurrence at 12-month follow-up. No ocular or systemic adverse effects from treatment were encountered. CONCLUSION: These results of intravitreal bevacizumab in myopic CNV are very promising with no apparent short-term safety concerns. At 12 months, treated eyes had a significant improvement in visual acuity (VA). OCT findings, as well, showed a trend consistent with the beneficial changes observed for VA. Treatment resulted in complete absence of angiographic leakage in 95% of eyes. Further studies will be needed to better determine long-term efficacy and safety
Codeposition of nickel–phosphorus alloys reinforced with boron carbide microparticles: direct and pulse plating
No full textNickel–phosphorus alloys were codeposited with boron carbide particles. Two compositions of nickel-phosphorus, one presenting a low phosphorus content in the order of 4% wt. and another one presenting a high phosphorus content of about 12% wt., were deposited from modified Watts nickel electrolytes using both direct and pulse plating. A strong influence of the deposition method was observed on the phosphorus content in the matrix and on the quantity of codeposited particles. Pulse plating was found to significantly increase both of them. Nucleation of the pure nickel–phosphorus alloy and of the codeposit were studied using chronoamperometry and AFM in potentiostatic mode. An instantaneous nucleation mechanism was evidenced on iron and gold substrates. Microhardness was measured and linked to the phosphorous and particle contents
Environmental and health-related external costs of meat consumption in Italy: estimations and recommendations through life cycle assessment
Get PDFThe literature on the external costs of food consumption is limited. This study aims at advancing in this field by translating the environmental and health-related impacts generated by the life-cycle of meat into external costs via monetization. The main types of meat consumed in Italy are used as a case study. The potential external costs are estimated via attributional life cycle assessment (LCA), using: i) the ReCiPe method for the environmental impact assessment (fourteen impact categories), ii) the population attributional fractions for the health damage from meat ingestion, and iii) the CE Delft environmental prices for monetization. Results show that processed pork and beef generate the highest costs on society, with an external cost of approximately 2€ per 100 g. Fresh pork and poultry follow, with a cost of 1€ and 0.5€ per 100 g, respectively. For comparison, the potential external costs of legumes (i.e., a plant-based alternative to meat) are estimated to be from eight to twenty times lower than meat (around 0.05€ per 100 g of legumes). In 2018, meat consumed in Italy potentially generated a cost on society of 36.6 bn€. The burden arises almost equally from impacts generated before meat ingestion (mainly associated with the emissions arisen from farming), and after the ingestion (due to diseases potentially associated with meat consumption). A sensitivity analysis on the main parameters revealed a large uncertainty on the final yearly cost, ranging from 19 to 93 bn€. Although more research is needed to improve the accuracy and the validity of the models used in the study (e.g., human health impact assessment, monetization) and to include potential external costs currently unaccounted for (e.g., water use, animal welfare, occupational health), results show unequivocal significant costs associated with meat consumption. We thus advocate for policies aimed at reducing these costs and allocating them properly
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Get PDF“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Appropriate Similarity Measures for Author Cocitation Analysis
Get PDFWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Dispelling the Myths Behind First-author Citation Counts
Get PDFWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
Choroidal Neovascularization in Pathologic Myopia: Intravitreal Ranibizumab Versus Bevacizumab—A Randomized Controlled Trial
No full texttreating myopic choroidal neovascularization (CNV). ? DESIGN: Prospective, comparative, randomized, interventional study. ? METHODS: Thirty-two eyes from 32 patients with myopic CNV were consecutively enrolled and randomly treated, in a 1:1 ratio, with intravitreal ranibizumab (0.5 mg) or bevacizumab (1.25 mg) as needed, after the first injection. ETDRS best-corrected visual acuity (BCVA), foveal center thickness (FCT) on optical coherence tomography (OCT), and fluorescein angiographic findings were examined before and after treatment. Patients were followed up for 6 months. ? RESULTS: No statistically significant difference in the BCVA improvement, as well as in the FCT reduction, was found between groups during follow-up (P value at 1, 3, 6 months > .05). Complete resolution of fluorescein leakage was observed in all 16 bevacizumab-treated eyes and in 15 out of 16 (93.7%) ranibizumab-treated eyes. No ocular or systemic adverse effects from treatment were encountered. ? CONCLUSION: This randomized clinical study cannot determine a statistically significant difference in anti- VEGF treatment effect between ranibizumab and bevacizumab for the treatment of CNV secondary to pathologic myopia. A larger study is required to determine the relative efficacy and duration of action of these drugs. (Am J Ophthalmol 2010;149:458–464. © 2010 by Elsevier Inc. All rights reserved.
- …
